Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-20-025305

Chief Commercial Officer acquired 1,207,457 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Evanson Jeff · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-03-19 Grant or award : show line 1 in the form +1,207,457 1,207,457 D
Loading xslF345X03/doc4.xml…